EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
9 06-2022

The European Brain Council launches “Migraine, my brain” campaign to rethink migraine care

2022-06-17T16:02:06+00:0009-06-2022|News|

On the occasion of Migraine & Headache Awareness Month, the European Brain Council launches "Migraine, my brain" campaign to highlight the need to rethink migraine care. The campaign falls under  "RETHINKING Migraine in times of COVID-19", a research-driven project offering tangible policy changes to improve the lives of people living with migraine across Europe. [...]

25 04-2022

Visit the extended exhibition “Living with MS during COVID-19: A case for rethinking MS care in the EU”

2022-04-25T08:32:05+00:0025-04-2022|News|

On the occasion of Multiple Sclerosis Awareness Week 2022, the national extension of the virtual exhibition "Living with MS during COVID-19: A case for rethinking MS care in the EU" brings light to the impact of the COVID-19 pandemic on multiple sclerosis at country level. Impact of the COVID-19 pandemic on multiple sclerosis at [...]

8 04-2022

Resources for action in Ukraine

2022-06-30T12:00:07+00:0008-04-2022|Uncategorized|

Since the war in Ukraine began, the European Brain Council has been monitoring the situation closely and looking to identify ways it could provide support. The situation on the ground has had- and will continue to have - tremendous impact on the mental wellbeing of people, as well as immense disruption on regular, life-saving [...]

28 10-2021

Registration open for “Best practices for patient safety: An EU-wide view on the use of medicines off-label” event on 30 November 2021

2021-10-28T09:59:06+00:0028-10-2021|News|

The European Brain Council is pleased to invite you to register for the digital event "Best practices for patient safety: An EU-wide view on the use of medicines off-label" to be held virtually on 30 November 2021 at 14:30 - 16:00 CET. In 2016, the Declaration for Good Off-Label Use Practice was launched, supported by a [...]

27 05-2021

“Brain and machine: Improving MS care in a digital age”

2021-04-27T14:30:38+00:0027-05-2021|

  The rapid development of COVID-19 vaccines is perhaps the clearest example of cumulative medical innovationㅡand its undisputed power to transform lives. But scientific innovation has not been limited to the race for immunity. From telemedicine and portable diagnostics to digital therapeutics and blockchain, digital technologies are reshaping health-care delivery―and could play a transformative role [...]

27 05-2021

EBC launches “RETHINKING MS in times of COVID-19” on the occasion of World Multiple Sclerosis Day

2021-06-28T07:51:36+00:0027-05-2021|News|

On the occasion of the approaching World Multiple Sclerosis Day (30 May 2021), the European Brain Council is excited to announce the release of its new policy paper, "RETHINKING MS in times of COVID-19". This new paper is part of the main report "RETHINKING MS in Europe", a research-driven project offering tangible policy changes [...]

25 05-2021

Registration open for “Patient safety and informed consent: The importance of good off-label use practices” event on 17 June 2021

2021-05-25T11:13:44+00:0025-05-2021|News|

The European Brain Council is pleased to invite you to register for the digital event "Patient safety and informed consent: The importance of good off-label use practices" to be held virtually on 17 June 2021 at 14:30 - 16:00CET. The event is co-organised with EUCOPE. In 2016, the Declaration for Good Off-Label Use Practice was launched, supported [...]

13 04-2021

Registration for the 3rd Brain Innovation Days event open!

2021-04-13T14:32:06+00:0013-04-2021|News|

The Brain Innovation Days team is very pleased to announce that registration is now open for the third Brain Innovation Days event, to be held virtually on 27 April 2021 at 12:30 - 14:00 CET. This lunchtime interactive session will fall under the theme "Fast-tracking brain innovation in times of COVID-19". The last 14 [...]

Go to Top